Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Other Non-Current Liabilities: 2013

Historic Other Non-Current Liabilities for Capricor Therapeutics (CAPR) over the last 1 years, with Dec 2013 value amounting to $4.0 million.

  • Capricor Therapeutics' Other Non-Current Liabilities rose 2672.92% to $11.3 million in Q1 2014 from the same period last year, while for Mar 2014 it was $11.3 million, marking a year-over-year increase of 2672.92%. This contributed to the annual value of $4.0 million for FY2013, which is N/A change from last year.
  • Per Capricor Therapeutics' latest filing, its Other Non-Current Liabilities stood at $4.0 million for FY2013.
  • In the past 5 years, Capricor Therapeutics' Other Non-Current Liabilities ranged from a high of $4.0 million in FY2013 and a low of $4.0 million during FY2013.
  • Its 1-year average for Other Non-Current Liabilities is $4.0 million, with a median of $4.0 million in 2013.